Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Alessandra Doolan"'
Publikováno v:
Applied Sciences, Vol 7, Iss 3, p 276 (2017)
Analysis of current literature highlights a wide variation in reported infection risk for different materials in cranial repair. The purpose of these composite materials are to mimic natural bone and assist in restoring function (structurally and aes
Externí odkaz:
https://doaj.org/article/91cde8345ac042b3a9fadee3ecfa0dca
Autor:
Jeremy Kwarcinski, Andrew J. Ruys, Omprakash Damodaran, Alessandra Doolan, James M. van Gelder, Philip Boughton
Publikováno v:
ANZ Journal of Surgery. 91:1226-1232
Background To clinically evaluate 3D print-formed implant process, using cranioplasty as a proof of concept, to examine its effectiveness and utility as a method of intraoperative implant fabrication. Methods Twelve patients had a 3D print-formed tem
Autor:
Christine L Chiu, Jodie Ingles, Christopher Semsarian, Alessandra Doolan, Neil E. I. Langlois, Joanne M. Lind
Publikováno v:
International Journal of Cardiology. 127:138-141
The cause of sudden death in young people remains unknown in up to 50% of postmortem cases. Mutations in the ion channel genes are known to cause primary arrhythmogenic disorders such as long QT and Brugada syndromes, which can present with sudden ca
Autor:
Jessica Chung, Christopher Semsarian, Iwan A. Williams, John E.J. Rasko, Alessandra Doolan, Emily Tu, Lan Nguyen, Tatiana Tsoutsman, David G. Allen, Charles G. Bailey, Lien Lam
Publikováno v:
Journal of Molecular and Cellular Cardiology. 41:623-632
Gene mutations in cardiac troponin I (cTnI) account for up to 5% of genotyped families with familial hypertrophic cardiomyopathy (FHC). Little is known about how cTnI mutations cause disease. Five lines of transgenic mice were generated which overexp
Publikováno v:
Diabetes Care. 28:806-809
OBJECTIVE—This study examines the use of HLA typing for the diagnosis of celiac disease in a group of Australians with type 1 diabetes. RESEARCH DESIGN AND METHODS—Subjects included 131 sequential patients with type 1 diabetes (mean age 17 years
Publikováno v:
Heart, Lung and Circulation. 13:15-25
Hypertrophic cardiomyopathy (HCM) is a disorder which has fascinated clinicians for many years. The remarkable diversity in clinical presentations, ranging from no symptoms to severe heart failure and sudden cardiac death, illustrates the complexity
Publikováno v:
Medical Journal of Australia. 180:110-112
Objectives: To determine the causes of sudden cardiac death in people aged 35 years or younger. Design and setting: A review of all autopsies performed between 1 January 1994 and 31 December 2002 at a major Sydney forensic medicine department serving
Autor:
Alessandra Doolan, Jonathan G. Seidman, Christine L Chiu, Christopher Semsarian, Jodie Ingles, Christine E. Seidman
Publikováno v:
Scopus-Elsevier
To report the frequency of single and multiple gene mutations in an Australian cohort of patients with hypertrophic cardiomyopathy (HCM).Genetic screening of seven HCM genes (beta-MHC, MyBP-C, cTnT, cTnI, ACTC, MYL2, and MYL3) was undertaken in 80 un
Autor:
Anne Trimmer, Alessandra Doolan
Publikováno v:
Medical Journal of Australia. 199:240-241
Autor:
Robert G. Weintraub, Lien Lam, Jessica Chung, Tatiana Tsoutsman, Christine L Chiu, Jodie Ingles, Alessandra Doolan, Lan Nguyen, Molly Tebo, Christopher Semsarian
Publikováno v:
Journal of molecular and cellular cardiology. 38(2)
Background. – Hypertrophic cardiomyopathy (HCM) is an autosomal dominant disorder caused by mutations in sarcomeric proteins. Cardiac troponin I (cTnI) is a key switch molecule in the sarcomere. Mutations in cTnI have been identified in Methods.